Takayuki Takahama

7PUBLICATIONS
24CO-AUTHORS
Molecular targetsCellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Aged care nursingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2026
Beyond exon 19 and 21: positioning lazertinib and the next generation of strategies for uncommon EGFR mutations.

|Feb 13, 2025
Detection of Overlooked Rare EGFR Mutations in Non-small Cell Lung Cancer Using Multigene Testing.

Naoki Shiraishi, Takayuki Takahama, Kazuko Sakai

|Dec 18, 2024
Evaluation of immune checkpoint inhibitor efficacy for solid tumors with CD274 (PD-L1 gene) amplification identified by comprehensive genomic profiling: retrospective study based on a nationwide database.

Tomohiro Nakayama, Takayuki Takahama, Yasutaka Chiba

|Jun 06, 2024
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.

Luis G Paz-Ares, Oscar Juan-Vidal, Giannis S Mountzios

|Mar 10, 2023
Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma.

Yasuo Otsuka, Yoriaki Komeda, Masayuki Takeda

|Nov 01, 2020
Predicting osimertinib-treatment outcomes through EGFR mutant-fraction monitoring in the circulating tumor DNA of EGFR T790M-positive patients with non-small cell lung cancer (WJOG8815L).

Kazuko Sakai, Takayuki Takahama, Mototsugu Shimokawa

Pageof 2

Frequent Collaborators

2 joint publications

Masayuki Takeda

1 joint publications

Isamu Okamoto

1 joint publications

Hiroaki Akamatsu

1 joint publications

Akira Ono